Koninklijke Philips: Solid Execution Supports Our Buy Rating
Comparable sales increased 4%, with growth across all segments and a particularly strong 13% contribution from emerging markets. Philips delivered €132 million of savings in Q2 and €258 million in H1, supporting a material improvement in adjusted EBITA margins. Rolling 12-month order intake rose 5%, free cash flow reached €222 million, and leverage remained manageable at approximately 1.8x EBITDA.
Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down
PHG lifts its 2026 profit and free cash flow outlook after Q2 earnings increase on higher sales, productivity gains and a U.S. tariff refund benefit.
Koninklijke Philips N.V. (PHG) Q2 2026 Earnings Call Transcript
Koninklijke Philips N.V. (PHG) Q2 2026 Earnings Call Transcript
Philips Shares Fall After Orders Slip
Shares in Philips fell as much as 11% in early European morning trade, wiping out the stock's gains since the start of the year.
Koninklijke Philips Q2 Earnings Call Highlights
Koninklijke Philips NYSE: PHG reported 4.1% comparable sales growth in the second quarter of 2026, supported by growth across all segments, while maintaining its full-year underlying sales and profitability outlook amid higher tariffs, cost inflation and continued weakness in China's health systems market.
Royal Philips Reports Increase in Sales, Comparable-Sales Growth
The Dutch health-technology company said customer demand for its products remains healthy, with large orders in North America shifting into the third quarter, while Europe delivered strong double-digit growth.
Royal Philips (PHG) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AI is boosting accuracy for clinicians, Philips North America CEO says
Artificial intelligence is helping improve accuracy in patient care and in some cases saving time and money, according to a survey sponsored by Philips , which provides diagnostic, imaging, and cloud technology to the healthcare industry, the CEO of its North American division said.
Here's Why Royal Philips (PHG) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Royal Philips (PHG) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Koninklijke Philips: AI Upside, And Margin Expansion Create An Attractive Entry Point
Productivity initiatives, cost discipline, and portfolio transformation continue to support earnings growth. Philips' extensive installed base and proprietary healthcare datasets position the company to capitalize on AI-enabled healthcare applications. Following a solid Q1 print-out, and combined with a potential recovery in EU MedTech sentiment, we believe this creates scope for both earnings growth and multiple expansion. We remain buyers.
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
